Advertisement

Topics

"RPM International Inc.∨derfield=date∨derval=DESC" News Stories

10:40 EDT 16th July 2019 | BioPortfolio

Here are the most relevant search results for "RPM International Inc.∨derfield=date∨derval=DESC" found in our extensive news archives from over 250 global news sources.

More Information about RPM International Inc.∨derfield=date∨derval=DESC on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about RPM International Inc.∨derfield=date∨derval=DESC for you to read. Along with our medical data and news we also list RPM International Inc.∨derfield=date∨derval=DESC Clinical Trials, which are updated daily. BioPortfolio also has a large database of RPM International Inc.∨derfield=date∨derval=DESC Companies for you to search.

Showing "International derfield date derval DESC" News Articles 1–25 of 10,000+

Tuesday 16th July 2019

Doctors and Scientists Launch Inaugural Workshop to Address Health Disparities in Alzheimer’s

Speakers Call for Human-Based Research Methods to Better Represent Alzheimer’s Patient Population Researchers, clinicians, advocates, and funders assembled for a roundtable discussion on preclinical strategies to reduce health disparities in dementia research Monday evening at the JW Marriott Los Angeles. An ancillary event to the Alzheimer’s Association International Conference, the roundta...


Contagion® Adds MAD-ID® to Its Strategic Alliance Partnership Program

Contagion®, the nation’s leading multimedia resource dedicated to providing up-to-date, disease-specific information to health care practitioners and specialists in the field of infectious diseases, announces the addition of Making A Difference in Infectious Diseases (MAD-ID®) to its Strategic Alliance Partnership (SAP) program. “We are very excited to be partnering with the MAD-ID® org...

Detailed Review of Tebentafusp (IMCgp100) in Metastatic Uveal Melanoma Published in Issue of Cancers

Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announce the publication of “Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma” in a special issue on uveal melanoma in Cancers, an international, peer-reviewed monthly journal.1 Written by Dr. Bertil Damato, Dr. Richard Carvajal and experts at Imm


Sigrid Therapeutics announces that all patients have completed treatment with SiPore15 in the STAR Trial

First-in-Class MSP (mesoporous silica particle) based therapy targets blood sugar and other metabolic risk factors. Stockholm, Sweden, July 16, 2019 – Sigrid Therapeutics AB, a biotechnology company developing a new class of therapies for metabolic diseases and disorders, today announces that all patients have completed treatment with SiPore15 in the STAR trial. Development is well on...

LivaNova Combats Leg Ischemia with Breakthrough Bidirectional Cannula

CE Marked Bi-Flow is the only cannula designed to prevent leg ischemia during cardiac procedures requiring femoral artery cannulation LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today launched its innovative arterial femoral cannula, Bi-Flow, designed to prevent limb ischemia during cardiac surgery. LivaNova Bi-Flow received CE Mark earlier this year and is the on...

Bumrungrad International Hospital Launches Medication Tourism: Patients Access Quality Specialty Pharmaceuticals, Vaccines and Specialized Treatment at Lower Cost

Visit www.bumrungrad.com/usa to get details about exciting medication tourism opportunities in Thailand With the introduction of a Medication Tourism program that makes specialty pharmaceuticals, vaccines and specialized care conveniently available to patients at up to 80 percent savings,

Qiagen Biorobot 8000 HAW-00000079 Pump Control Board

$115.00 (0 Bids)End Date: Monday Jul-22-2019 20:04:11 PDTBid now | Add to watch list Biotech365 : Qiagen Biorobot 8000 HAW-00000079 Pump Control Board BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool or a Bioinformatic … Continue reading →

St. Luke’s Medical Center Selects Allscripts Sunrise™

Allscripts client in Philippines to provide first-of-its-kind acute care services St. Luke’s Medical Center, located in the Philippines, has selected Allscripts (NASDAQ: MDRX) Sunrise™ Acute Care as its electronic health record (EHR) to achieve the goal of standardization across its facilities via a single, integrated EHR. St. Luke’s Medical Center further represents the company’s growin...

Delaware Innovation Space Launches an Entrepreneurial Advisory Council

Leaders from across the United States join forces with the Delaware Innovation Space to assist science startups The Delaware Innovation Space is proud to announce the formation of the Entrepreneurial Advisory Council (the EAC) for the Delaware Innovation Space and is pleased to introduce its foundational class which includes the following experts with diverse perspectives from across the country...

Sproutly Announces Plans to Launch BioNatural Oil Products Under CALIBER Brand

Not for Dissemination in the US or Through US Newswire Services Sproutly Canada, Inc. (CSE:SPR) (OTCQB:SRUTF) (FSE:38G) (“Sproutly" or the “Company”) is pleased to provide an update on its premium cannabis brand for the recreational market, CALIBER, as it plans to launch premium cannabis oil products utilizing its BioNatural Oil (“BNO”), a unique and differentiated cannabis oil produce...

Halo Announces Lease Buy Down of its California Facilities

Falcon Agrees to Take Common Shares In Lieu of Future Lease Payments Not for Distribution to U.S. Newswire Servicers or For Dissemination in the United States Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has entered into an agreement with Falcon International (“Falcon”) to buy out the entire rental premium of its Californi...

TILT Holdings Announces U.S. $125 Million Convertible Note Financing

Proposed financing would provide the capital to accelerate the runway for growth across business units and continue the TILT mission to deliver value to shareholders TILT Holdings Inc. (“TILT” or the “Company”) (CSE: TILT) (OTCQB: SVVTF) today announced that it has signed a binding term sheet for a private placement of US $125 million from a syndicate of institutional investors (the “F...

Ra Pharmaceuticals and Camurus Announce Exclusive License Agreement for FluidCrystal® Extended Release Formulation of Zilucoplan

FluidCrystal® extended release formulation of zilucoplan achieved rapid and sustained pharmacodynamic inhibition of complement C5 in non-human primates, supporting at least once weekly dosing Ra Pharmaceuticals, Inc. (Nasdaq:RARX) and Camurus AB (Nasdaq STO:CAMX) today announced an exclusive worldwide license agreement for the use of Camurus’s proprietary FluidCrystal® (FC) technology to dev...

Did You Invest In Galapagos?

Shares of Galapagos NV (GLPG), which touched an all-time high of $174.63 in intraday trading on Monday, have gained 90 percent year-to-date. GLPG was trading around $55 when we alerted our premium subscribers to this stock on July 17, 2015.

LifeSpan BioSciences Announces the Acquisition of Everest Biotech

LifeSpan BioSciences (LSBio™), a leading provider of antibodies and life science research reagents, is pleased to announce its acquisition of Everest Biotech. Everest Biotech are ISO 9001:2015 certified experts in antigen affinity purified goat polyclonal antibodies. The acquisition of Everest Biotech further expands LSBio’s product offering and strengthens the company’s position as one o...

AsclepiX Therapeutics Selected to Present at Ophthalmology Innovation Summit (OIS) at the American Society for Retinal Surgeons (ASRS) Annual Conference

To Provide Update on AXT107 Duration of Efficacy Maintained for Over Thirteen Months to Date in Animal Models AXT107 Inhibits VEGF and Activates Tie2 with Potential Once Yearly Dosing BALTIMORE, MD / ACCESSWIRE / July 16, 2019 / AsclepiX Therapeutics, Inc., a biopharmaceutical company focused on the use of artificial intelligence (AI) to discover, design, dev

ReNeuron granted international patents over cell technology

The stem cell specialist now has 40 patents worldwide

FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)

Novartis International AG / FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101) . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. FDA grants crizanlizumab Priority Review based on Phase II data showing prevention of vaso-occlusive crises (VOCs) in pa...

AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury

Financing co-led by new investors LSP and Andera Partners, with participation of existing investors Forbion, Ysios Capital, Kurma Partners, ID Invest Partners, BB Pureos Bioventures and Gilde Healthcare Proceeds to be used for the 1,400-patient international pivotal Phase III trial of recombinant human Alkaline Phosphatase (recAP) in patients with sepsis-associated acute kidney injury (SA-AKI)...

Theralase Receives Notice of Acceptance for Multiwavelength Photo Dynamic Therapy from Russian Patent Office

TORONTO, ON / ACCESSWIRE / July 16, 2019 / Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (“PDC”) and their associated drug formulations to safely and effectively destroy various cancers is pleased to announce that the Russ...

EMMAC Acquires 100% of Terra Verde

Terra Verde holds oldest cannabis cultivation licence in Portugal Establishes EMMAC as the largest vertically integrated medical cannabis and wellness company in Europe EMMAC Life Sciences Ltd (“EMMAC” or the “Company”), the leading European independent medical cannabis and wellness company, is pleased to announce that it has acquired 100% of Terra Verde, LDA (“Terra Verde”), a Port...

Monday 15th July 2019

Biocompatible breast implants manufactured by BellaSeno now ISO standard certified

BellaSeno, a company that develops absorbable breast implants using 3D printing, today announced it has obtained full ISO 13485 certification – the international QMS standard for medical devices The post Biocompatible breast implants manufactured by BellaSeno now ISO standard certified appeared first on NS Medical Devices.

AHF: Clock Is Ticking, WHO – Act Now on Ebola!

With the first reported case of Ebola emerging this week in Goma, a populous city in the eastern Democratic Republic of the Congo (DRC) next to the Rwandan city of Gisenyi, medical care providers and public health advocates from AIDS Healthcare Foundation (AHF) are speaking out loudly—declaring that the time has come for immediate action from World Health Organization (

Changing habits: China's pig farms clean up to beat swine fever

A devastating outbreak of African swine fever that has killed millions of pigs in China is changing attitudes in a country where farm hygiene has often been seen as lax by international standards.

Field research in Turkmenistan's highest mountain reveals high biological diversity

(Pensoft Publishers) Well-known for its unique landscapes and rare wildlife, the Koytendag State Nature Reserve was yet to reveal the scale of its actual biodiversity when a series of international expeditions, coordinated and funded by the Royal Society for the Protection of Birds (RSPB) began to explore the site in 2013. As a result, a comprehensive report describing its remarkable biodiversity ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks